Enliven Therapeutics Inc (ELVN)

Cost of Revenue

$60.00K

TTM · Period ending: · USD

ELVN logo

ELVN Cost of Revenue

Latest reported$60.00K
ELVN TTM Cost of Revenue ($0.00 → $60.00K)
High-resolution chart · PNG

ELVN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Enliven Therapeutics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
60,000
60,000
46,000
0
0
0
0
0
0
0
0
0
0
0
0
0
24,000
49,000
74,000
74,000
50,000
25,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.